New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...

Research reveals a link between Ozempic and Wegovy, popular weight loss and diabetes medications, and an increased risk of ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

Popular weight loss drug, semaglutide, could be shrinking the muscle tissue in the heart, a new study has found. In recent ...

Ozempic isn’t approved for weight loss but that's a famous side effect, so some doctors have been prescribing it off-label ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.